Sleep is another frequently discussed benefit
The findings, published in the journal Diabetes, Obesity and Metabolism, provide real-world context to previous randomized clinical trials indicating that patients who stopped semaglutide (sold under the brand names Ozempic/Wegovy) and tirzepatide (sold under the brand names Mounjaro/Zepbound) regained more than half of the weight they lost within 12 months
Common symptoms Bloating related to GLP-1 treatment can present in several ways
What to expect: Improved sleep depth and quality Subtle energy improvements Possible injection site reactions (mild, temporary) Phase 2: Optimization (Months 2-3) Benefits become more noticeable as growth hormone levels optimize
If you are on less than 2,000 mg daily and tolerating it well, there may be room to increase
We did not observe significant correlation between total GSH level and BACS scores in SZ and BP